News
AbbVie ducks bolt-on trend and agrees Allergan mega-merger US drugmaker AbbVie has agreed to buy struggling Allergan in a $63 billion deal that continues a slew of multibillion dollar takeovers in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback